13F Filings History of IRON Financial LLC

Latest 13F report
Q4 2025 - 22 Jan 2026
Value $
$217,566,645
Signature - Title
Timothy Ziemba - Chief Compliance Officer
Location
Northbrook, IL
Summary
This page shows a list of all the recent 13F filings made by IRON Financial LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. IRON Financial LLC reported 132 stock holdings with total value $217,566,645 as of Q4 2025. Top holdings included AAPL, ISTB, CME, VTI, and SPTM.

Notify me when IRON Financial LLC files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q4 2025 132 $217,566,645 +$16,073,228 -$9,335,583 +$6,737,645 AAPL, ISTB, CME, VTI, SPTM 13F-HR 22 Jan 2026, 14:52
Q3 2025 139 $208,821,558 +$28,771,051 -$17,818,398 +$10,952,653 ISTB, AAPL, CME, VTI, SPTM 13F-HR 24 Oct 2025, 14:29
Q2 2025 121 $188,918,541 +$7,515,497 -$4,459,544 +$3,055,953 CME, AAPL, VTI, ISTB, HTRB 13F-HR 24 Jul 2025, 17:53
Q1 2025 113 $178,388,959 +$17,805,298 -$17,444,723 +$360,575 CME, AAPL, HTRB, ISTB, VTI 13F-HR 25 Apr 2025, 11:43
Q4 2024 104 $178,002,093 +$10,293,277 -$10,589,609 -$296,332 AAPL, CME, HTRB, VTI, ISTB 13F-HR 22 Jan 2025, 14:45
Q3 2024 108 $183,747,118 +$16,162,282 -$20,630,378 -$4,468,096 AAPL, CME, HTRB, VTI, SPTM 13F-HR 28 Oct 2024, 12:41
Q2 2024 101 $178,326,810 +$5,869,566 -$6,963,954 -$1,094,388 AAPL, HTRB, CME, VTI, SPTM 13F-HR 29 Jul 2024, 16:58
Q1 2024 98 $179,405,944 +$11,743,456 -$13,689,392 -$1,945,936 CME, HTRB, AAPL, VTI, SPTM 13F-HR 23 Apr 2024, 10:41
Q4 2023 98 $176,213,883 +$4,229,998 -$12,127,073 -$7,897,075 CME, AAPL, HTRB, VTI, SPTM 13F-HR 19 Jan 2024, 15:23
Q3 2023 97 $172,285,853 +$9,537,841 -$19,235,838 -$9,697,997 CME, HTRB, AAPL, VTI, SPTM 13F-HR 31 Oct 2023, 15:06
Q2 2023 100 $186,040,306 +$3,862,767 -$5,150,183 -$1,287,416 CME, HTRB, AAPL, VTI, SPTM 13F-HR 24 Jul 2023, 16:02
Q1 2023 97 $182,155,472 +$21,903,569 -$23,175,374 -$1,271,805 CME, HTRB, AAPL, SCHP, ISTB 13F-HR 25 Apr 2023, 18:21
Q4 2022 97 $174,192,431 +$6,984,084 -$19,205,876 -$12,221,792 SPSB, HTRB, CME, SCHP, AAPL 13F-HR 14 Feb 2023, 14:45
Q3 2022 93 $182,135,000 +$10,616,049 -$9,403,214 +$1,212,835 SPSB, HTRB, CME, SCHP, AAPL 13F-HR 14 Nov 2022, 13:14
Q2 2022 96 $190,980,000 +$8,051,835 -$11,363,291 -$3,311,456 SPSB, HTRB, CME, SCHP, AAPL 13F-HR 27 Jul 2022, 15:24
Q1 2022 111 $216,981,000 +$23,542,329 -$22,100,436 +$1,441,893 SPSB, HTRB, CME, AAPL, SCHP 13F-HR 04 May 2022, 11:28
Q4 2021 115 $224,184,000 +$8,696,144 -$3,887,475 +$4,808,669 HTRB, SPSB, CME, AAPL, VTI 13F-HR 11 Feb 2022, 15:27
Q3 2021 110 $208,478,000 +$14,239,763 -$17,075,663 -$2,835,900 HTRB, SPSB, CME, VTI, AAPL 13F-HR 02 Nov 2021, 10:33
Q2 2021 107 $213,705,000 +$32,112,094 -$16,094,132 +$16,017,962 HTRB, SPSB, CME, VTI, SCHP 13F-HR 28 Jul 2021, 09:55
Q1 2021 104 $189,510,000 +$49,550,421 -$63,554,626 -$14,004,205 SPSB, HTRB, CME, VTI, ACWV 13F-HR 07 May 2021, 12:15
Q4 2020 122 $198,690,000 +$12,768,134 -$9,445,948 +$3,322,186 HTRB, ACWV, CME, SPY, AAPL 13F-HR 13 Jan 2021, 14:40
Q3 2020 102 $181,015,000 +$27,067,285 -$42,332,630 -$15,265,345 HTRB, ACWV, CME, SPY, AAPL 13F-HR 09 Nov 2020, 10:43
Q2 2020 110 $193,744,000 +$47,284,708 -$29,492,348 +$17,792,360 SPSB, HTRB, ACWV, CME, SPY 13F-HR 15 Jul 2020, 10:31
Q1 2020 107 $159,518,000 +$14,621,420 -$38,297,494 -$23,676,074 HTRB, CME, ACWV, SPY, SPSB 13F-HR 20 Apr 2020, 09:49
Q4 2019 118 $209,596,000 +$76,377,363 -$7,467,585 +$68,909,778 CME, HTRB, SPY, FTSM, ACWV 13F-HR 30 Jan 2020, 17:21
Q3 2019 100 $134,037,000 +$30,669,624 -$13,055,480 +$17,614,144 CME, SPY, VTI, ACWV, USMV 13F-HR 21 Oct 2019, 15:15
Q2 2019 88 $106,500,000 +$4,031,816 -$55,254,928 -$51,223,112 CME, SPY, SPTM, VTI, SPDW 13F-HR 02 Aug 2019, 10:04
Q1 2019 94 $158,062,000 +$36,303,538 -$17,199,068 +$19,104,470 SPTM, CME, TTAC, SPY, SHYG 13F-HR 08 May 2019, 10:51
Q4 2018 79 $128,222,000 +$17,840,173 -$25,245,713 -$7,405,540 SPY, CME, SPTM, TTAC, VTI 13F-HR 15 Jan 2019, 13:42
Q3 2018 88 $148,987,000 +$34,831,817 -$75,775,679 -$40,943,862 SPTM, CME, TTAC, VTI, SPY 13F-HR 18 Oct 2018, 12:20
Q2 2018 97 $182,655,000 +$51,035,327 -$24,969,871 +$26,065,456 SPY, MINT, CME, SPTM, SPSB 13F-HR 30 Jul 2018, 14:37
Q1 2018 88 $155,792,000 +$40,506,299 -$28,729,661 +$11,776,638 SPY, VTI, CME, MINT, TOTL 13F-HR 23 Apr 2018, 14:33
Q4 2017 85 $143,882,000 +$21,594,810 -$13,350,257 +$8,244,553 VTI, SPY, PHB, CME, TOTL 13F-HR 30 Jan 2018, 11:42
Q3 2017 72 $131,099,000 +$26,611,179 -$12,302,774 +$14,308,405 VTI, SPY, CME, TOTL, VXUS 13F-HR 23 Oct 2017, 15:57
Q2 2017 76 $112,817,000 +$16,481,219 -$45,388,183 -$28,906,964 VTI, SPY, CME, VXUS, VCSH 13F-HR 31 Jul 2017, 16:53
Q1 2017 87 $138,760,000 +$12,868,574 -$24,873,683 -$12,005,109 VTI, HYG, CME, JNK, PHB 13F-HR 02 May 2017, 14:37
Q4 2016 79 $146,423,000 +$70,927,172 -$8,749,121 +$62,178,051 JNK, VTI, HYG, PHB, CME 13F-HR 27 Jan 2017, 14:48
Q3 2016 75 $81,910,000 +$4,510,190 -$3,789,258 +$720,932 VTI, CME, VXUS, SPY, VCSH 13F-HR 03 Nov 2016, 15:03
Q2 2016 71 $77,611,000 +$4,759,316 -$26,529,430 -$21,770,114 VTI, CME, VXUS, SPY, VCSH 13F-HR 28 Jul 2016, 13:54
Q1 2016 83 $99,044,000 +$12,150,287 -$31,795,882 -$19,645,595 VTI, CME, VXUS, SPY, JNK 13F-HR 11 Apr 2016, 13:53
Q4 2015 91 $117,586,000 +$22,850,092 -$57,412,776 -$34,562,684 VTI, CME, SPY, HYG, JNK 13F-HR 19 Jan 2016, 11:52
Q3 2015 90 $150,238,000 +$61,402,814 -$11,599,834 +$49,802,980 SPY, VTI, CME, JNK, KRE 13F-HR 27 Oct 2015, 17:05
Q2 2015 75 $106,075,000 +$20,291,948 -$41,997,835 -$21,705,887 VTI, SPY, CME, VIG, VCSH 13F-HR 30 Jul 2015, 14:33
Q1 2015 72 $128,097,000 +$21,670,772 -$19,036 +$21,651,736 SPY, VTI, CME, XLF, VIG 13F-HR 09 Apr 2015, 14:27
Q4 2014 91 $110,998 $0 $0 $0 ON SEMICONDUCTO, NUVASIVE INC SR, TAKE TWO INTERA, MACQUARIE INFRA, MEDICINES CO SR 13F-HR 29 Jan 2015, 15:34
Q3 2014 70 $77,281,000 +$11,434,894 -$44,549,628 -$33,114,734 VTI, CME, XLF, XLV, VIG 13F-HR 21 Oct 2014, 18:14
Q2 2014 80 $113,102,000 +$34,095,106 -$53,489,933 -$19,394,827 SPY, VTI, AMJ, CME, VIG 13F-HR 30 Jul 2014, 09:16
Q1 2014 76 $131,122,000 +$40,196,754 -$7,552,773 +$32,643,981 SPY, VTI, CME, VIG, VCSH 13F-HR 07 May 2014, 17:01
Q4 2013 42 $98,032,000 $0 $0 $0 SPY, VTI, CME, VIG, CWB 13F-HR 08 Jan 2014, 16:09